BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17803748)

  • 1. Pharmacokinetic disposition and bioavailability of cefepime in buffalo calves.
    Joshi B; Sharma SK
    J Vet Pharmacol Ther; 2007 Oct; 30(5):500-2. PubMed ID: 17803748
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative disposition kinetics of ofloxacin following a single i.m. and s.c. administration in neonatal calves.
    Gaur A; Garg SK; Saini SP
    J Vet Pharmacol Ther; 2005 Oct; 28(5):485-8. PubMed ID: 16207313
    [No Abstract]   [Full Text] [Related]  

  • 3. Disposition kinetics, bioavailability and renal clearance of cefepime in calves.
    Ismail MM
    Vet Res Commun; 2005 Jan; 29(1):69-79. PubMed ID: 15727293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioavailability of cefquinome in rabbits following intravenous and intramuscular administration.
    Hwang YH; Song IB; Lee HK; Kim TW; Kim MS; Lim JH; Park BK; Yun HI
    J Vet Pharmacol Ther; 2011 Dec; 34(6):618-20. PubMed ID: 21615754
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of cefepime administered by i.v. and i.m. routes to ewes.
    Ismail M
    J Vet Pharmacol Ther; 2005 Dec; 28(6):499-503. PubMed ID: 16343281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability of cefquinome in healthy ducks.
    Yuan L; Sun J; Wang R; Sun L; Zhu L; Luo X; Fang B; Liu Y
    Am J Vet Res; 2011 Jan; 72(1):122-6. PubMed ID: 21194344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a single intramuscular injection of cefquinome in buffalo calves.
    Venkatachalam D; Dumka VK; Ranjan B
    J Vet Pharmacol Ther; 2018 Feb; 41(1):155-158. PubMed ID: 28891215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ceftiofur after single intravenous and intramuscular administration in camels (Camelus dromedarius).
    Goudah A
    J Vet Pharmacol Ther; 2007 Aug; 30(4):371-4. PubMed ID: 17610412
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to neonatal calves.
    Fernández-Varón E; Escudero-Pastor E; Cárceles-Rodríguez CM
    Vet J; 2005 May; 169(3):437-43. PubMed ID: 15848786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profile of cefquinome after oral subchronic flubendiamide exposure and in vitro plasma protein binding in buffalo calves.
    Venkatachalam D; Dumka VK
    Environ Toxicol Pharmacol; 2015 Jan; 39(1):321-6. PubMed ID: 25546120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interactions of marbofloxacin with anti-inflammatory drugs in buffalo calves.
    Baroni EE; Rubio S; Rodríguez C; De Lucas JJ; Fernández H; Andrés MS
    Vet Rec; 2011 Aug; 169(7):182. PubMed ID: 21771762
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of a continuous rate infusion of ceftiofur sodium in normal foals.
    Wearn JM; Davis JL; Hodgson DR; Raffetto JA; Crisman MV
    J Vet Pharmacol Ther; 2013 Feb; 36(1):99-101. PubMed ID: 22606991
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of endotoxin induced fever on the pharmacokinetics of intramuscularly administered cefepime in rabbits.
    Goudah A; Mouneir SM; Shim JH; Abd El-Aty AM
    J Vet Sci; 2006 Jun; 7(2):151-5. PubMed ID: 16645340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of different doses of cisplatin on the pharmacokinetic parameters of cefepime in mice.
    Máthé A; Komka K; Forczig M; Szabó D; Anderlik P; Rozgonyi F
    Lab Anim; 2006 Jul; 40(3):296-300. PubMed ID: 16803647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic indices of marbofloxacin after intravenous, subcutaneous, and intramuscular administrations in buffalo calves (<10 days old).
    Lüders C; Baroni EE; Rubio S; De Lucas JJ; Díaz DC; San Andrés MI
    J Vet Pharmacol Ther; 2012 Jun; 35(3):301-4. PubMed ID: 21812790
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of E. coli lipopolysaccharide induced fever on the plasma kinetics of cefepime in cross-bred calves.
    Pawar YG; Sharma SK
    Vet Res Commun; 2008 Feb; 32(2):123-30. PubMed ID: 17610035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of cefquinome and ceftriaxone in premature calves.
    Corum O; Yildiz R; Ider M; Altan F; Ok M; Uney K
    J Vet Pharmacol Ther; 2019 Nov; 42(6):632-639. PubMed ID: 31197850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS; Paladino JA; Schentag JJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of cefquinome in crossbred wild boars.
    Liu B; Zhang C; Zhang X; Yang S; Yu J; Sun J; Liu Y
    J Vet Pharmacol Ther; 2012 Dec; 35(6):611-4. PubMed ID: 22221167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.